News | News By Subject | News by Disease News By Date | Search News

Growth Hormone Insensitivity Syndrome (GHIS) News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News

News from Around the Web
No News Posted on that date

Press Releases
Versartis, Inc. (VSAR) Presents Confirmatory 18-Month Adherence Data From Ongoing Somavaratan Extension Study At Late-Breaker Session At ENDO Annual Meeting     4/1/2016
Versartis, Inc. (VSAR) Presents Confirmatory 18-Month Data From Ongoing Somavaratan Extension Study At Late-Breaker Session At ESPE Annual Meeting     10/1/2015
FDA Approves Genentech (RHHBY)'s Drug To Treat Children's Growth Disorder     3/24/2015
Versartis, Inc. (VSAR) Presents 12-Month Data For VRS-317 At Late-Breaker Session At Endocrine Society's Annual Meeting     3/9/2015
Versartis, Inc. (VSAR) Initiates Global Phase 3 Study Of VRS-317 In Children With Growth Hormone Deficiency     1/8/2015
Versartis, Inc. (VSAR) Announces Positive 12 Month Data For VRS-317 from Ongoing Extension Study     1/5/2015
Addex Therapeutics (ADXN.SW) Validates Potential Efficacy Biomarker for Phase 1 Trial of Its GABA-B Positive Allosteric Modulator, ADX71441     5/21/2013
Chiasma Inc.'s Octreolin(TM) (Oral Octreotide) Shown to Inhibit Growth Hormone in Healthy Subjects     6/6/2011
Altus Pharmaceuticals Inc. Announces Completion Of Clinical Testing In The Phase I Study Of ALTU-238, A Long-Acting Crystalline Formulation Of Human Growth Hormone     6/6/2005
Insmed Incorporated (INSM) Reports Detailed Positive Results From Its Pivotal Clinical Trial Of SomatoKine In Patients With Growth Hormone Insensitivity Syndrome     6/1/2005

//-->